The expression levels of CD154 in CD4+ T lymphocytes correlate well with disease severity, clinical outcomes and disease remission as well as therapeutic response to anti-TNF treatment in RA patients [8,9,10]. The gene discussed is TNF; the disease is rheumatoid arthritis.